Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 183 articles:
HTML format

Single Articles

    January 2023

  1. Expression of Concern: Corticosteroids Mediate Heart Failure-Induced Depression through Reduced sigma1-Receptor Expression.
    PLoS One. 2023;18:e0279803.

  2. TEE C, Xu H, Fu X, Cui D, et al
    Longitudinal HbA1c trajectory modelling reveals the association of HbA1c and risk of hospitalization for heart failure for patients with type 2 diabetes mellitus.
    PLoS One. 2023;18:e0275610.
    PubMed     Abstract available

  3. LEE K, Lee SK, Lee J, Jeon BK, et al
    Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus.
    PLoS One. 2023;18:e0280359.
    PubMed     Abstract available

  4. EL MAJZOUB I, Kalot N, Khalifeh M, Estelly N, et al
    "Predictors of in-hospital mortality in adult cancer patients with COVID-19 infection presenting to the emergency department: A retrospective study".
    PLoS One. 2023;18:e0278898.
    PubMed     Abstract available

  5. CONNOCK M, Auguste P, Obadia JF, Andronis L, et al
    Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair.
    PLoS One. 2023;18:e0280554.
    PubMed     Abstract available

  6. ALCOBERRO L, Moliner P, Vime J, Jimenez-Marrero S, et al
    Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failure.
    PLoS One. 2023;18:e0279815.
    PubMed     Abstract available

  7. SONG Y, Leem J, Dhanani M, McKirnan MD, et al
    Impact of blood factors on endothelial cell metabolism and function in two diverse heart failure models.
    PLoS One. 2023;18:e0281550.
    PubMed     Abstract available

  8. LIU T, Xuan H, Wang L, Li X, et al
    The association between serum albumin and long length of stay of patients with acute heart failure: A retrospective study based on the MIMIC-IV database.
    PLoS One. 2023;18:e0282289.
    PubMed     Abstract available

  9. LI D, Fu J, Zhao J, Qin J, et al
    A deep learning system for heart failure mortality prediction.
    PLoS One. 2023;18:e0276835.
    PubMed     Abstract available

  10. GANDIN I, Saccani S, Coser A, Scagnetto A, et al
    Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: A retrospective cohort study.
    PLoS One. 2023;18:e0281878.
    PubMed     Abstract available

  11. HU T, Yao W, Li Y, Liu Y, et al
    Interaction of acute heart failure and acute kidney injury on in-hospital mortality of critically ill patients with sepsis: A retrospective observational study.
    PLoS One. 2023;18:e0282842.
    PubMed     Abstract available

  12. BORCHERS P, Pfisterer D, Scherpf M, Voigt K, et al
    Needs- and user-oriented development of contactless camera-based telemonitoring in heart disease-Results of an acceptance survey from the Home-based Healthcare Project (feasibility project).
    PLoS One. 2023;18:e0282527.
    PubMed     Abstract available

  13. ANJULLO BB, Kumaso SK, Erango MA
    Joint modeling of longitudinal change in pulse rate and survival time of heart failure patients treated at Arbaminch General Hospital, Southern Ethiopia.
    PLoS One. 2023;18:e0282637.
    PubMed     Abstract available

  14. CALLAHAN K, Acharya Y, Hollenbeak CS
    Validity of ICD codes to identify do-not-resuscitate orders among older adults with heart failure: A single center study.
    PLoS One. 2023;18:e0283045.
    PubMed     Abstract available

  15. MULUGETA H, Sinclair PM, Wilson A
    Prevalence of depression and its association with health-related quality of life in people with heart failure in low- and middle-income countries: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0283146.
    PubMed     Abstract available

  16. BERGMARK RW, Jin G, Semco RS, Santolini M, et al
    Association of hospital centrality in inter-hospital patient-sharing networks with patient mortality and length of stay.
    PLoS One. 2023;18:e0281871.
    PubMed     Abstract available

    January 2022
  17. XU Z, Neuber S, Nazari-Shafti T, Liu Z, et al
    Impact of procedural variability and study design quality on the efficacy of cell-based therapies for heart failure - a meta-analysis.
    PLoS One. 2022;17:e0261462.
    PubMed     Abstract available

  18. LI M, Li Y, Meng Q, Li Y, et al
    Correction: Effects of nurse-led transitional care interventions for patients with heart failure on healthcare utilization: A meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0262979.
    PubMed     Abstract available

  19. SHIBA M, Kato T, Morimoto T, Yaku H, et al
    Changes in BNP levels from discharge to 6-month visit predict subsequent outcomes in patients with acute heart failure.
    PLoS One. 2022;17:e0263165.
    PubMed     Abstract available

  20. LIU X, Liu H, Wang L, Zhang L, et al
    Role of sacubitril-valsartan in the prevention of atrial fibrillation occurrence in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0263131.
    PubMed     Abstract available

  21. TONNESSEN TC, Melleby AO, Hauge-Iversen IM, Espe EKS, et al
    Impact of delayed type hypersensitivity arthritis on development of heart failure by aortic constriction in mice.
    PLoS One. 2022;17:e0262821.
    PubMed     Abstract available

  22. SAKUMA M, Toyoda S, Arikawa T, Koyabu Y, et al
    Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial.
    PLoS One. 2022;17:e0261445.
    PubMed     Abstract available

  23. ZHENG S, Yang J, Tan TC, Belani S, et al
    Dialysis therapy and mortality in older adults with heart failure and advanced chronic kidney disease: A high-dimensional propensity-matched cohort study.
    PLoS One. 2022;17:e0262706.
    PubMed     Abstract available

  24. SHIBATA T, Oishi S, Mizuno A, Ohmori T, et al
    Evaluation of the effectiveness of the physician education program on primary palliative care in heart failure.
    PLoS One. 2022;17:e0263523.
    PubMed     Abstract available

  25. CHAPMAN-GOETZ J, Packham N, Gabb G, Potts C, et al
    Acceptability and feasibility of the NPS MedicineWise mobile phone application in supporting medication adherence in patients with chronic heart failure: Protocol for a pilot study.
    PLoS One. 2022;17:e0263284.
    PubMed     Abstract available

  26. MARSHALL V, Jewett-Tennant J, Shell-Boyd J, Stevenson L, et al
    Healthcare providers experiences with shared medical appointments for heart failure.
    PLoS One. 2022;17:e0263498.
    PubMed     Abstract available

  27. LI N, Zhou G, Zheng Y, Lv D, et al
    Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis.
    PLoS One. 2022;17:e0261986.
    PubMed     Abstract available

  28. SONG J, Zhang Q, Ye L, Zheng Y, et al
    The comparison of catheter ablation on hard outcomes versus medical treatment for atrial fibrillation patients: A meta-analysis of randomized, controlled trials with trial sequential analysis.
    PLoS One. 2022;17:e0262702.
    PubMed     Abstract available

  29. ZHANG Y, Van Laer AO, Baicu CF, Neff LS, et al
    Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.
    PLoS One. 2022;17:e0262479.
    PubMed     Abstract available

  30. HODREA J, Saeed A, Molnar A, Fintha A, et al
    SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
    PLoS One. 2022;17:e0263285.
    PubMed     Abstract available

  31. ALTAMURA M, D'Andrea G, Angelini E, Tortorelli FMP, et al
    Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients.
    PLoS One. 2022;17:e0265282.
    PubMed     Abstract available

  32. KUJAWSKI SA, Whitaker M, Ritchey MD, Reingold AL, et al
    Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure-United States, 2015-2017.
    PLoS One. 2022;17:e0264890.
    PubMed     Abstract available

  33. WAJANGA BMK, Kim CY, Peck RN, Bartlett J, et al
    Is lack of health insurance a predictor of worsening of heart failure among adult patients attending referral hospitals in Northwestern Tanzania?
    PLoS One. 2022;17:e0264352.
    PubMed     Abstract available

  34. DE JONG KA, Berisha F, Naderpoor N, Appelbe A, et al
    Polycystic ovarian syndrome increases prevalence of concentric hypertrophy in normotensive obese women.
    PLoS One. 2022;17:e0263312.
    PubMed     Abstract available

  35. LEE HJ, Kim HK, Lee SC, Ommen SR, et al
    Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
    PLoS One. 2022;17:e0264580.
    PubMed     Abstract available

  36. HARRISON NE, Meram S, Li X, White MB, et al
    Hemodynamic profiles by non-invasive monitoring of cardiac index and vascular tone in acute heart failure patients in the emergency department: External validation and clinical outcomes.
    PLoS One. 2022;17:e0265895.
    PubMed     Abstract available

  37. SAAD NS, Mashali MA, Elnakish MT, Hare A, et al
    Effect of hypothyroidism on contractile performance of isolated end-stage failing human myocardium.
    PLoS One. 2022;17:e0265731.
    PubMed     Abstract available

  38. SHROUT TA, Pan S, Mitchell GF, Vasan RS, et al
    Association of orthostatic blood pressure response with incident heart failure: The Framingham Heart Study.
    PLoS One. 2022;17:e0267057.
    PubMed     Abstract available

  39. BANERAS J, Pariggiano I, Rodenas-Alesina E, Oristrell G, et al
    Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics: Who and how.
    PLoS One. 2022;17:e0266955.
    PubMed     Abstract available

  40. ANDERSON KM, Murphy D, Groninger H, Kolm P, et al
    Perceived symptoms as the primary indicators for 30-day heart failure readmission.
    PLoS One. 2022;17:e0267820.
    PubMed     Abstract available

  41. YAMAMOTO E, Kato T, Yaku H, Morimoto T, et al
    Appetite loss at discharge from acute decompensated heart failure: Observation from KCHF registry.
    PLoS One. 2022;17:e0267327.
    PubMed     Abstract available

  42. RIMBAS RC, Visoiu IS, Magda SL, Mihaila-Baldea S, et al
    New insights into the potential utility of the left atrial function analysis in heart failure with preserved ejection fraction diagnosis.
    PLoS One. 2022;17:e0267962.
    PubMed     Abstract available

  43. SHARA N, Bjarnadottir MV, Falah N, Chou J, et al
    Voice activated remote monitoring technology for heart failure patients: Study design, feasibility and observations from a pilot randomized control trial.
    PLoS One. 2022;17:e0267794.
    PubMed     Abstract available

  44. DOI T, Noto T, Mita T, Nagahara D, et al
    Prognostic value of nutritional parameters in systolic heart failure with renal dysfunction.
    PLoS One. 2022;17:e0266839.
    PubMed     Abstract available

  45. MONREAL G, Koenig SC, Slaughter MS, Morello GF, et al
    Feasibility testing of the Inspired Therapeutics NeoMate mechanical circulatory support system for neonates and infants.
    PLoS One. 2022;17:e0266822.
    PubMed     Abstract available

  46. GUARDINO CE, Pan S, Vasan RS, Xanthakis V, et al
    Multi-system trajectories and the incidence of heart failure in the Framingham Offspring Study.
    PLoS One. 2022;17:e0268576.
    PubMed     Abstract available

  47. HIGA Y, Nabeshima Y, Kitano T, Kataoka M, et al
    Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays.
    PLoS One. 2022;17:e0268895.
    PubMed     Abstract available

  48. LERTSUTTIMETTA T, Tumkosit M, Kaveevorayan P, Chantranuwatana P, et al
    The discrepancies between clinical and histopathological diagnoses of cardiomyopathies in patients with stage D heart failure undergoing heart transplantation.
    PLoS One. 2022;17:e0269019.
    PubMed     Abstract available

  49. LIND L, Zethelius B, Byberg L
    Self-reported physical activity and different cardiovascular diseases-Results from updated measurements over 40 years.
    PLoS One. 2022;17:e0269402.
    PubMed     Abstract available

  50. SANDSTEDT M, Vukusic K, Ulfenborg B, Jonsson M, et al
    Human intracardiac SSEA4+CD34 cells show features of cycling, immature cardiomyocytes and are distinct from Side Population and C-kit+CD45- cells.
    PLoS One. 2022;17:e0269985.
    PubMed     Abstract available

  51. NI L, Miao P, Jiang J, Wan F, et al
    Glycyrrhiza uralensis promote the metabolism of toxic components of Aconitum carmichaeli by CYP3A and alleviate the development of chronic heart failure.
    PLoS One. 2022;17:e0270069.
    PubMed     Abstract available

  52. TIGABE TEKLE M, Bekalu AF, Tefera YG
    Length of hospital stay and associated factors among heart failure patients admitted to the University Hospital in Northwest Ethiopia.
    PLoS One. 2022;17:e0270809.
    PubMed     Abstract available

  53. WU J, Wang W, Huang Y, Wu H, et al
    Deletion of SM22alpha disrupts the structure and function of caveolae and T-tubules in cardiomyocytes, contributing to heart failure.
    PLoS One. 2022;17:e0271578.
    PubMed     Abstract available

  54. KIM Y, Canada JM, Kenyon J, Billingsley H, et al
    Physical activity, sedentary behaviors and all-cause mortality in patients with heart failure: Findings from the NHANES 2007-2014.
    PLoS One. 2022;17:e0271238.
    PubMed     Abstract available

  55. ZHU L, Marsh JW, Griffith MP, Collins K, et al
    Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021.
    PLoS One. 2022;17:e0271381.
    PubMed     Abstract available

  56. HAN JH, McNaughton CD, Stubblefield WB, Pang PS, et al
    Delirium and its association with short-term outcomes in younger and older patients with acute heart failure.
    PLoS One. 2022;17:e0270889.
    PubMed     Abstract available

  57. KANG JO, Ha TW, Jung HU, Lim JE, et al
    A cardiac-null mutation of Prdm16 causes hypotension in mice with cardiac hypertrophy via increased nitric oxide synthase 1.
    PLoS One. 2022;17:e0267938.
    PubMed     Abstract available

  58. AMIROVA A, Lucas R, Cowie MR, Haddad M, et al
    Perceived barriers and enablers influencing physical activity in heart failure: A qualitative one-to-one interview study.
    PLoS One. 2022;17:e0271743.
    PubMed     Abstract available

  59. ALCARAZ A, Pichon-Riviere A, Rojas-Roque C, Gonzalez JM, et al
    Cost-effectiveness of a centrifugal-flow pump for patients with advanced heart failure in Argentina.
    PLoS One. 2022;17:e0271519.
    PubMed     Abstract available

  60. GUO YG, Zhang Y, Liu WL
    The causal relationship between allergic diseases and heart failure: Evidence from Mendelian randomization study.
    PLoS One. 2022;17:e0271985.
    PubMed     Abstract available

  61. SMITH KB, Potters TO, Zenarosa GL
    Pretransplant survival of patients with end-stage heart failure under competing risks.
    PLoS One. 2022;17:e0273100.
    PubMed     Abstract available

  62. TAJEU GS, Colvin CL, Hardy ST, Bress AP, et al
    Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study.
    PLoS One. 2022;17:e0270675.
    PubMed     Abstract available

  63. VIGORE M, Granata N, Braga SS, Piaggi G, et al
    Cognitive impairment, frailty and rehabilitation outcome in older cardiorespiratory patients. DEC_FRAinRIAB: Study protocol.
    PLoS One. 2022;17:e0272132.
    PubMed     Abstract available

  64. PRADELLA M, Anastasopoulos C, Yang S, Moor M, et al
    Associations between fully-automated, 3D-based functional analysis of the left atrium and classification schemes in atrial fibrillation.
    PLoS One. 2022;17:e0272011.
    PubMed     Abstract available

  65. MAZUR A, Brat K, Homolka P, Merta Z, et al
    Ventilatory efficiency is superior to peak oxygen uptake for prediction of lung resection cardiovascular complications.
    PLoS One. 2022;17:e0272984.
    PubMed     Abstract available

  66. CHEN Z, Li M, Yin C, Fang Y, et al
    Effects of cardiac rehabilitation on elderly patients with Chronic heart failure: A meta-analysis and systematic review.
    PLoS One. 2022;17:e0273251.
    PubMed     Abstract available

  67. KOGEL A, Hepp P, Stegmann T, Tunnemann-Tarr A, et al
    Effects of surgical and FFP2 masks on cardiopulmonary exercise capacity in patients with heart failure.
    PLoS One. 2022;17:e0269470.
    PubMed     Abstract available

  68. AKAMA J, Shimizu T, Ando T, Anzai F, et al
    Clinical usefulness of the pattern of non-adherence to anti-platelet regimen in stented patients (PARIS) thrombotic risk score to predict long-term all-cause mortality and heart failure hospitalization after percutaneous coronary intervention.
    PLoS One. 2022;17:e0274287.
    PubMed     Abstract available

  69. SADAT-EBRAHIMI SR, Rezabakhsh A, Aslanabadi N, Asadi M, et al
    Novel diagnostic potential of miR-1 in patients with acute heart failure.
    PLoS One. 2022;17:e0275019.
    PubMed     Abstract available

  70. SLADE AL, O'Hara ME, Quinn D, Marley L, et al
    Living with a left ventricular assist device: Capturing recipients experiences using group concept mapping software.
    PLoS One. 2022;17:e0273108.
    PubMed     Abstract available

  71. MA S, Wang DH
    Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction.
    PLoS One. 2022;17:e0274618.
    PubMed     Abstract available

  72. LIU S, Li J, Qu Z, Li R, et al
    The effectiveness of eHealth self-management interventions in patients with chronic heart failure: Protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0268446.
    PubMed     Abstract available

  73. FUKUTA H, Hagiwara H, Kamiya T
    Hypoxia-inducible factor prolyl hydroxylase inhibitors for anemia in heart failure patients: A protocol for systematic review and meta-analysis.
    PLoS One. 2022;17:e0275311.
    PubMed     Abstract available

  74. SEDLACEK K, Polasek R, Jansova H, Grieco D, et al
    Inadvertent QRS prolongation by an optimization device-based algorithm in patients with cardiac resynchronization therapy.
    PLoS One. 2022;17:e0275276.
    PubMed     Abstract available

  75. HUANG J, Tang X, Liang X, Wen Q, et al
    Correction: The Effects of 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone on the Pressure Overload-Induced Progression of Cardiac Hypertrophy to Cardiac Failure.
    PLoS One. 2022;17:e0276104.
    PubMed     Abstract available

  76. HUSSEN NM, Workie DL, Biresaw HB
    Survival time to complications of congestive heart failure patients at Felege Hiwot comprehensive specialized referral hospital, Bahir Dar, Ethiopia.
    PLoS One. 2022;17:e0276440.
    PubMed     Abstract available

  77. LIM J, Hwang IC, Choi HM, Yoon YE, et al
    Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior cardiovascular or renal disease.
    PLoS One. 2022;17:e0269414.
    PubMed     Abstract available

  78. ROTH S, Fox H, M'Pembele R, Morshuis M, et al
    Noninvasive evaluation of the hemodynamic status in patients after heart transplantation or left ventricular assist device implantation.
    PLoS One. 2022;17:e0275977.
    PubMed     Abstract available

  79. BAIG M, Moafi-Madani M, Qureshi R, Roberts MB, et al
    Heart rate variability and the risk of heart failure and its subtypes in post-menopausal women: The Women's Health Initiative study.
    PLoS One. 2022;17:e0276585.
    PubMed     Abstract available

  80. WATSON DE, Marashi-Pour S, Tran B, Witchard A, et al
    Patient-reported experiences and outcomes following hospital care are associated with risk of readmission among adults with chronic health conditions.
    PLoS One. 2022;17:e0276812.
    PubMed     Abstract available

  81. TAKEDA T, Tsubaki A, Ikeda Y, Kato R, et al
    The impacts of preoperative frailty on readmission after cardiac implantable electrical device implantation.
    PLoS One. 2022;17:e0277115.
    PubMed     Abstract available

  82. PICKERING JW, Scrase R, Troughton R, Jamieson HA, et al
    Evaluation of the added value of Brain Natriuretic Peptide to a validated mortality risk-prediction model in older people using a standardised international clinical assessment tool.
    PLoS One. 2022;17:e0277850.
    PubMed     Abstract available

  83. LU Z, Teng Y, Wang L, Jiang Y, et al
    Abnormalities of hippocampus and frontal lobes in heart failure patients and animal models with cognitive impairment or depression: A systematic review.
    PLoS One. 2022;17:e0278398.
    PubMed     Abstract available

  84. CHOUAIRI F, Mullan CW, Ahmed A, Bhinder J, et al
    Clinical implications of Type 2 diabetes on outcomes after cardiac transplantation.
    PLoS One. 2022;17:e0273111.
    PubMed     Abstract available

  85. KING BL, Meyer ML, Chari SV, Hurka-Richardson K, et al
    Accuracy of the electronic health record's problem list in describing multimorbidity in patients with heart failure in the emergency department.
    PLoS One. 2022;17:e0279033.
    PubMed     Abstract available

  86. NEMOTO H, Umemura M, Suzuki F, Nagasako A, et al
    Store-operated calcium entry via ORAI1 regulates doxorubicin-induced apoptosis and prevents cardiotoxicity in cardiac fibroblasts.
    PLoS One. 2022;17:e0278613.
    PubMed     Abstract available

  87. PFEFFER TJ, Neuser J, Mueller-Leisse J, Hohmann S, et al
    Acute echocardiographic and electrocardiographic effects of triggered left ventricular pacing.
    PLoS One. 2022;17:e0278531.
    PubMed     Abstract available

  88. KAWAJI T, Shizuta S, Tanaka M, Nishiwaki S, et al
    Prognostic impact of catheter ablation in patients with asymptomatic atrial fibrillation.
    PLoS One. 2022;17:e0279178.
    PubMed     Abstract available

  89. SOLNICK RE, Vijayasiri G, Li Y, Kocher KE, et al
    Emergency department returns and early follow-up visits after heart failure hospitalization: Cohort study examining the role of race.
    PLoS One. 2022;17:e0279394.
    PubMed     Abstract available

  90. NDONGALA NJ, Maepa C, Nyondo E, Amstutz A, et al
    Etiology, characteristics and occurrence of heart diseases in rural Lesotho (ECHO-Lesotho): A retrospective echocardiography cohort study.
    PLoS One. 2022;17:e0278406.
    PubMed     Abstract available

  91. CHO DH, Lee CJ, Son JW, Choi J, et al
    Temporal trends in heart failure over 11 years in the aging Korean population: A retrospective study using the national health insurance database.
    PLoS One. 2022;17:e0279541.
    PubMed     Abstract available

  92. YEH TH, Tu KC, Hung KC, Chuang MH, et al
    Impact of type of dialyzable beta-blockers on subsequent risk of mortality in patients receiving dialysis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0279680.
    PubMed     Abstract available

  93. CHEN EW, Ahmad K, Erqou S, Wu WC, et al
    Particulate matter 2.5, metropolitan status, and heart failure outcomes in US counties: A nationwide ecologic analysis.
    PLoS One. 2022;17:e0279777.
    PubMed     Abstract available

  94. TORIBIO M, Awadalla M, Drobni ZD, Quinaglia T, et al
    Cardiac strain is lower among women with HIV in relation to monocyte activation.
    PLoS One. 2022;17:e0279913.
    PubMed     Abstract available

    January 2021
  95. ISHAK WW, Korouri S, Darwish T, Vanle B, et al
    Personalized treatments for depressive symptoms in patients with advanced heart failure: A pragmatic randomized controlled trial.
    PLoS One. 2021;16:e0244453.
    PubMed     Abstract available

  96. LU XH, Liu A, Fuh SC, Lian Y, et al
    Recurrent disease progression networks for modelling risk trajectory of heart failure.
    PLoS One. 2021;16:e0245177.
    PubMed     Abstract available

  97. YAMAZAKI R, Nishiyama O, Yoshikawa K, Saeki S, et al
    HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure.
    PLoS One. 2021;16:e0245778.
    PubMed     Abstract available

  98. ALHABIB KF, Gamra H, Almahmeed W, Hammoudeh A, et al
    Correction: Acute Myocardial Infarction and Acute Heart Failure in the Middle East and North Africa: Study Design and Pilot Phase Study Results from the PEACE MENA Registry.
    PLoS One. 2021;16:e0246036.
    PubMed     Abstract available

  99. KAMATH DY, Bhuvana KB, Salazar LJ, Varghese K, et al
    A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failure.
    PLoS One. 2021;16:e0245659.
    PubMed     Abstract available

  100. OGUNTADE AS, Ajayi IO
    Risk factors of heart failure among patients with hypertension attending a tertiary hospital in Ibadan, Nigeria: The RISK-HHF case-control study.
    PLoS One. 2021;16:e0245734.
    PubMed     Abstract available

  101. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
    Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
    PLoS One. 2021;16:e0247145.
    PubMed     Abstract available

  102. FUNAMIZU T, Nagatomo Y, Saji M, Iguchi N, et al
    Low muscle mass assessed by psoas muscle area is associated with clinical adverse events in elderly patients with heart failure.
    PLoS One. 2021;16:e0247140.
    PubMed     Abstract available

  103. YOLA IM, Oh A, Mitchell GF, O'Connor G, et al
    Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
    PLoS One. 2021;16:e0246355.
    PubMed     Abstract available

  104. PIERCE JB, Shah NS, Petito LC, Pool L, et al
    Trends in heart failure-related cardiovascular mortality in rural versus urban United States counties, 2011-2018: A cross-sectional study.
    PLoS One. 2021;16:e0246813.
    PubMed     Abstract available

  105. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
    PLoS One. 2021;16:e0247987.
    PubMed     Abstract available

  106. MCHORNEY CA, Mansukhani SG, Anatchkova M, Taylor N, et al
    The impact of heart failure on patients and caregivers: A qualitative study.
    PLoS One. 2021;16:e0248240.
    PubMed     Abstract available

  107. PUWANANT S, Sinphurmsukskul S, Krailak L, Nakaviroj P, et al
    The impact of the coronavirus disease and Tele-Heart Failure Clinic on cardiovascular mortality and heart failure hospitalization in ambulatory patients with heart failure.
    PLoS One. 2021;16:e0249043.
    PubMed     Abstract available

  108. KAWADA K, Fukuda H, Kubo T, Ohta T, et al
    Added value of anxiolytic benzodiazepines in predictive models on severe delirium in patients with acute decompensated heart failure: A retrospective analysis.
    PLoS One. 2021;16:e0250372.
    PubMed     Abstract available

  109. BAMFORTH RJ, Chhibba R, Ferguson TW, Sabourin J, et al
    Strategies to prevent hospital readmission and death in patients with chronic heart failure, chronic obstructive pulmonary disease, and chronic kidney disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249542.
    PubMed     Abstract available

  110. ABE D, Inomata T
    Actual state of "triple therapy" for heart failure patients in eight regions of Japan: An analysis of a nationwide medical claims database.
    PLoS One. 2021;16:e0249711.
    PubMed     Abstract available

  111. MBOTWA JL, Kamps M, Baxter PD, Ellison GTH, et al
    Latent class regression improves the predictive acuity and clinical utility of survival prognostication amongst chronic heart failure patients.
    PLoS One. 2021;16:e0243674.
    PubMed     Abstract available

  112. LUPON J, Santiago-Vacas E, Cediel G, Codina P, et al
    Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
    PLoS One. 2021;16:e0249674.
    PubMed     Abstract available

  113. KANDA M, Tateishi K, Nakagomi A, Iwahana T, et al
    Association between early intensive care or coronary care unit admission and post-discharge performance of activities of daily living in patients with acute decompensated heart failure.
    PLoS One. 2021;16:e0251505.
    PubMed     Abstract available

  114. PONGIGLIONE B, Torbica A, Gale CP, Tavazzi L, et al
    Patient, hospital and country-level risk factors of all-cause mortality among patients with chronic heart failure: Prospective international cohort study.
    PLoS One. 2021;16:e0250931.
    PubMed     Abstract available

  115. ALGUREN B, Jernberg T, Vasko P, Selb M, et al
    Content comparison and person-centeredness of standards for quality improvement in cardiovascular health care.
    PLoS One. 2021;16:e0244874.
    PubMed     Abstract available

  116. ABID L, Charfeddine S, Kammoun I, Ben Halima M, et al
    Epidemiology of heart failure and long-term follow-up outcomes in a north-African population: Results from the NAtional TUnisian REgistry of Heart Failure (NATURE-HF).
    PLoS One. 2021;16:e0251658.
    PubMed     Abstract available

  117. CHOU YY, Ward JL, Barron LZ, Murphy SD, et al
    Focused ultrasound of the caudal vena cava in dogs with cavitary effusions or congestive heart failure: A prospective, observational study.
    PLoS One. 2021;16:e0252544.
    PubMed     Abstract available

  118. TAKAHASHI S, Tanno K, Yonekura Y, Ohsawa M, et al
    Low educational level increases functional disability risk subsequent to heart failure in Japan: On behalf of the Iwate KENCO study group.
    PLoS One. 2021;16:e0253017.
    PubMed     Abstract available

  119. MAHESRI M, Chin K, Kumar A, Barve A, et al
    External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.
    PLoS One. 2021;16:e0252903.
    PubMed     Abstract available

  120. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Cardiac index predicts long-term outcomes in patients with heart failure.
    PLoS One. 2021;16:e0252833.
    PubMed     Abstract available

  121. KATO M, Mori Y, Watanabe D, Onoda H, et al
    Relationship between average daily rehabilitation time and decline in instrumental activity of daily living among older patients with heart failure: A preliminary analysis of a multicenter cohort study, SURUGA-CARE.
    PLoS One. 2021;16:e0254128.
    PubMed     Abstract available

  122. KAWASE Y, Kato T, Morimoto T, Hata R, et al
    Admission systolic blood pressure as a prognostic predictor of acute decompensated heart failure: A report from the KCHF registry.
    PLoS One. 2021;16:e0253999.
    PubMed     Abstract available

  123. TANIGUCHI C, Seto N, Shimizu Y
    Outpatient nursing support for self-monitoring in patients with chronic heart failure.
    PLoS One. 2021;16:e0254019.
    PubMed     Abstract available

  124. HAMO CE, Abdelmoneim SS, Han SY, Chandy E, et al
    OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).
    PLoS One. 2021;16:e0253014.
    PubMed     Abstract available

  125. GOLAND S, Volodarsky I, Fabricant Y, Livschitz S, et al
    Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
    PLoS One. 2021;16:e0254104.
    PubMed     Abstract available

  126. CHO JH, Leong D, Cuk N, Ebinger JE, et al
    Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
    PLoS One. 2021;16:e0254641.
    PubMed     Abstract available

  127. PRATTIPATI S, Sakita FM, Kweka GL, Tarimo TG, et al
    Heart failure care and outcomes in a Tanzanian emergency department: A prospective observational study.
    PLoS One. 2021;16:e0254609.
    PubMed     Abstract available

  128. LOKAJ P, Spinar J, Spinarova L, Malek F, et al
    Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction.
    PLoS One. 2021;16:e0255271.
    PubMed     Abstract available

  129. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Variable effects of underlying diseases on the prognosis of patients with COVID-19.
    PLoS One. 2021;16:e0254258.
    PubMed     Abstract available

  130. LI CX, Liang S, Gao L, Liu H, et al
    Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.
    PLoS One. 2021;16:e0244689.
    PubMed     Abstract available

  131. RORTH R, Clausen MF, Fosbol EL, Mogensen UM, et al
    Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer.
    PLoS One. 2021;16:e0255364.
    PubMed     Abstract available

  132. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
    Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
    PLoS One. 2021;16:e0255263.
    PubMed     Abstract available

  133. ACHARYA R, Patel A, Schultz E, Bourgeois M, et al
    Fluid resuscitation and outcomes in heart failure patients with severe sepsis or septic shock: A retrospective case-control study.
    PLoS One. 2021;16:e0256368.
    PubMed     Abstract available

  134. BECK-FRIIS J, Leach S, Omerovic E, Zeijlon R, et al
    No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not.
    PLoS One. 2021;16:e0256035.
    PubMed     Abstract available

  135. TURRI-SILVA N, Vale-Lira A, Verboven K, Quaglioti Durigan JL, et al
    High-intensity interval training versus progressive high-intensity circuit resistance training on endothelial function and cardiorespiratory fitness in heart failure: A preliminary randomized controlled trial.
    PLoS One. 2021;16:e0257607.
    PubMed     Abstract available

  136. CHOUAIRI F, Mullan CW, Ravindra N, Clark KAA, et al
    Brief report: Cannabis and opioid use disorder among heart failure admissions, 2008-2018.
    PLoS One. 2021;16:e0255514.
    PubMed     Abstract available

  137. RUFF C, Gerharz A, Groll A, Stoll F, et al
    Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
    PLoS One. 2021;16:e0250298.
    PubMed     Abstract available

  138. PERRY A, Loh F, Adamo L, Zhang KW, et al
    Unsupervised cluster analysis of patients with recovered left ventricular ejection fraction identifies unique clinical phenotypes.
    PLoS One. 2021;16:e0248317.
    PubMed     Abstract available

  139. CHUANG AM, Nguyen MT, Khan E, Jones D, et al
    Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
    PLoS One. 2021;16:e0248289.
    PubMed     Abstract available

  140. LV S, Ru S
    The prevalence of malnutrition and its effects on the all-cause mortality among patients with heart failure: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0259300.
    PubMed     Abstract available

  141. JONSSON HOLMDAHL A, Norberg H, Valham F, Bergdahl E, et al
    Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function.
    PLoS One. 2021;16:e0258949.
    PubMed     Abstract available

  142. IWAHANA T, Saito Y, Okada S, Kato H, et al
    Safety and efficacy of esaxerenone in Japanese hypertensive patients with heart failure with reduced ejection fraction: A retrospective study.
    PLoS One. 2021;16:e0259485.
    PubMed     Abstract available

  143. GALLARD A, Galli E, Hubert A, Bidaut A, et al
    Echocardiographic view and feature selection for the estimation of the response to CRT.
    PLoS One. 2021;16:e0252857.
    PubMed     Abstract available

  144. ITZHAKI BEN ZADOK O, Vaturi M, Vaxman I, Iakobishvili Z, et al
    Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.
    PLoS One. 2021;16:e0255487.
    PubMed     Abstract available

  145. KITAGAWA Y, Kawamura I, Suzuki K, Okada H, et al
    Serum syndecan-1 concentration in hospitalized patients with heart failure may predict readmission-free survival.
    PLoS One. 2021;16:e0260350.
    PubMed     Abstract available

  146. LI M, Li Y, Meng Q, Li Y, et al
    Effects of nurse-led transitional care interventions for patients with heart failure on healthcare utilization: A meta-analysis of randomized controlled trials.
    PLoS One. 2021;16:e0261300.
    PubMed     Abstract available

  147. DUONG SQ, Zheng L, Xia M, Jin B, et al
    Identification of patients at risk of new onset heart failure: Utilizing a large statewide health information exchange to train and validate a risk prediction model.
    PLoS One. 2021;16:e0260885.
    PubMed     Abstract available

  148. SUN Y, Pavey H, Wilkinson I, Fisk M, et al
    Role of the IL-33/ST2 axis in cardiovascular disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0259026.
    PubMed     Abstract available

  149. KIM IS, Choi YJ, Choi EY, Min PK, et al
    Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and >/=60 years.
    PLoS One. 2021;16:e0258770.
    PubMed     Abstract available

  150. MONGILLO J, Vescovo G, Bramanti B
    Belly fat or bloating? New insights into the physical appearance of St Anthony of Padua.
    PLoS One. 2021;16:e0260505.
    PubMed     Abstract available

  151. SCAGLIONE A, Panzarino C, Modica M, Tavanelli M, et al
    Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device.
    PLoS One. 2021;16:e0259927.
    PubMed     Abstract available

  152. JOKI Y, Konishi H, Ebinuma H, Takasu K, et al
    Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart disease.
    PLoS One. 2021;16:e0261753.
    PubMed     Abstract available

  153. SU MI, Liu CW
    Neutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia.
    PLoS One. 2021;16:e0252030.
    PubMed     Abstract available

  154. WANG B, Chen J
    Establishment and validation of a predictive model for mortality within 30 days in patients with sepsis-induced blood pressure drop: A retrospective analysis.
    PLoS One. 2021;16:e0252009.
    PubMed     Abstract available

    January 2020
  155. BLAZQUEZ-BERMEJO Z, Farre N, Llagostera M, Caravaca Perez P, et al
    The development of chronic diuretic resistance can be predicted during a heart-failure hospitalization. Results from the REDIHF registry.
    PLoS One. 2020;15:e0240098.
    PubMed     Abstract available

  156. CARABALLO C, McCullough M, Fuery MA, Chouairi F, et al
    COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system.
    PLoS One. 2020;15:e0238829.
    PubMed     Abstract available

  157. LI AH, Palmer KS, Taljaard M, Paterson JM, et al
    Effects of quality-based procedure hospital funding reform in Ontario, Canada: An interrupted time series study.
    PLoS One. 2020;15:e0236480.
    PubMed     Abstract available

  158. STOLINA M, Luo X, Dwyer D, Han CY, et al
    The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
    PLoS One. 2020;15:e0231234.
    PubMed     Abstract available

  159. OKANO T, Motoki H, Minamisawa M, Kimura K, et al
    Cardio-renal and cardio-hepatic interactions predict cardiovascular events in elderly patients with heart failure.
    PLoS One. 2020;15:e0241003.
    PubMed     Abstract available

  160. LANGSETH MS, Andersen GO, Husebye T, Arnesen H, et al
    Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure.
    PLoS One. 2020;15:e0241333.
    PubMed     Abstract available

  161. IACCARINO G, Grassi G, Borghi C, Carugo S, et al
    Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension.
    PLoS One. 2020;15:e0237297.
    PubMed     Abstract available

  162. VALENTE C, Guglielmini C, Domenech O, Contiero B, et al
    Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    PLoS One. 2020;15:e0238440.
    PubMed     Abstract available

  163. BAVISHI A, Lloyd-Jones DM, Ning H, Vu THT, et al
    Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure.
    PLoS One. 2020;15:e0240567.
    PubMed     Abstract available

  164. LIU N, Hang T, Gao X, Yang W, et al
    The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
    PLoS One. 2020;15:e0238775.
    PubMed     Abstract available

  165. ARMOIRY X, Obadia JF, Auguste P, Connock M, et al
    Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.
    PLoS One. 2020;15:e0241361.
    PubMed     Abstract available

  166. SOHN A, Speier W, Lan E, Aoki K, et al
    Integrating remote monitoring into heart failure patients' care regimen: A pilot study.
    PLoS One. 2020;15:e0242210.
    PubMed     Abstract available

  167. MORBACH C, Sahiti F, Tiffe T, Cejka V, et al
    Myocardial work - correlation patterns and reference values from the population-based STAAB cohort study.
    PLoS One. 2020;15:e0239684.
    PubMed     Abstract available

  168. MEZZACAPPA C, Ravindra NG, Caraballo C, Chouairi F, et al
    Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure.
    PLoS One. 2020;15:e0242928.
    PubMed     Abstract available

  169. CHECA C, Medina-Perucha L, Munoz MA, Verdu-Rotellar JM, et al
    Living with advanced heart failure: A qualitative study.
    PLoS One. 2020;15:e0243974.
    PubMed     Abstract available

  170. TING SW, Fan PC, Lin YS, Lin MS, et al
    Uremic pruritus and long-term morbidities in the dialysis population.
    PLoS One. 2020;15:e0241088.
    PubMed     Abstract available

  171. HAMMOND MM, Shen C, Li S, Kazi DS, et al
    Retrospective evaluation of echocardiographic variables for prediction of heart failure hospitalization in heart failure with preserved versus reduced ejection fraction: A single center experience.
    PLoS One. 2020;15:e0244379.
    PubMed     Abstract available

  172. KRUIK-KOLLOFFEL WJ, van der Palen J, Doggen CJM, van Maaren MC, et al
    Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.
    PLoS One. 2020;15:e0244231.
    PubMed     Abstract available

  173. VERHESTRAETEN C, Weijers G, Debleu D, Ciarka A, et al
    Diagnosis, treatment, and follow-up of heart failure patients by general practitioners: A Delphi consensus statement.
    PLoS One. 2020;15:e0244485.
    PubMed     Abstract available

  174. SATO Y, Yoshihisa A, Watanabe K, Hotsuki Y, et al
    Association between platelet distribution width and prognosis in patients with heart failure.
    PLoS One. 2020;15:e0244608.
    PubMed     Abstract available

  175. KATO T, Yaku H, Morimoto T, Inuzuka Y, et al
    Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study.
    PLoS One. 2020;15:e0243818.
    PubMed     Abstract available

  176. DASSANAYAKA S, Brittian KR, Long BW, Higgins LA, et al
    Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
    PLoS One. 2020;15:e0242250.
    PubMed     Abstract available

  177. HER AY, Choi BG, Rha SW, Kim YH, et al
    The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.
    PLoS One. 2020;15:e0242314.
    PubMed     Abstract available

  178. DE NATTES T, Litzler PY, Gay A, Nafeh-Bizet C, et al
    Hemolysis induced by Left Ventricular Assist Device is associated with proximal tubulopathy.
    PLoS One. 2020;15:e0242931.
    PubMed     Abstract available

  179. SALONEN J, Vahanikkila H, Purokivi M, Kaarteenaho R, et al
    Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
    PLoS One. 2020;15:e0242860.
    PubMed     Abstract available

  180. ROH SY, Choi JI, Kim MS, Cho EY, et al
    Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
    PLoS One. 2020;15:e0242799.
    PubMed     Abstract available

  181. JONES E, Wei J, Nelson MD, Bakir M, et al
    N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    PLoS One. 2020;15:e0243213.
    PubMed     Abstract available

  182. BARENFELD E, Ali L, Wallstrom S, Fors A, et al
    Becoming more of an insider: A grounded theory study on patients' experience of a person-centred e-health intervention.
    PLoS One. 2020;15:e0241801.
    PubMed     Abstract available

  183. KAZMI SZH, Habib N, Riaz R, Rizvi SS, et al
    Multiscale based nonlinear dynamics analysis of heart rate variability signals.
    PLoS One. 2020;15:e0243441.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.